Inclusion criteria:
- Patient with ankylosing spondylitis who was previously randomized in DRI11073 study (ALIGN) and have completed the 12 weeks treatment period
Exclusion criteria:
- Adverse event(s) having lead to treatment discontinuation in the DRI11073 study
- Event or laboratory abnormality observed at the last treatment visit of DRI11073 study that would adversely affect participation of the patient in this study as per investigator judgment
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01118728?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
